Simvastatin in patients with progressive multiple sclerosis--Authors' reply

Lancet. 2014 Sep 13;384(9947):952-3. doi: 10.1016/S0140-6736(14)61622-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Brain / pathology*
  • Disabled Persons*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
  • Male
  • Multiple Sclerosis, Chronic Progressive / drug therapy*
  • Simvastatin / administration & dosage*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Simvastatin